Dermatology
« Previous EntriesPsoriasis patients’ QoL impacts healthcare use independent of disease severity
Monday, August 30th, 2010Poor quality of life (QoL) in patients with psoriasis is associated with greater use of healthcare resources and employment disadvantages independently of disease severity, research suggests.
“From the patients perspective, psoriasis can have significant adverse effects on health-related QoL,” note Reiko Sato (Pfizer, Collegeville, Pennsylvania, USA) and colleagues.
“To improve their QoL, patients with psoriasis are likely […]
Characteristics of pediatric psoriasis outlined
Wednesday, August 4th, 2010Source: MedWire News
Children with psoriasis usually present with mild disease, predominantly of the plaque type, and boys are primarily affected, indicate the results of a Greek epidemiological study.
Prompted by the lack of epidemiological data for psoriasis in children, Christina Stefanaki and colleagues from Andreas Sygros Hospital in Athens collected information on 125 children diagnosed with […]
Seven-point checklist reasonably effective for diagnosing melanoma
Friday, March 12th, 2010Source: MedWire News
The seven-point checklist algorithm for detecting melanoma is relatively effective for predicting melanoma, but use of complementary information increases accuracy, show study results.
Holger Haenssle (Georg August University Göttingen, Germany) and colleagues assessed the diagnostic performance of the dermatoscopic seven-point checklist for diagnosing melanoma.
The seven criteria were defined as: gray-blue areas, atypical vascular pattern, […]
Combine current, emerging therapies to treat pigmentary disorders
Tuesday, August 18th, 2009Treating tough pigmentary disorders requires combining current therapies while keeping abreast of emerging therapies, including new sunscreens, resurfacing procedures and promising monotherapeutic bleaching agents and oral treatments, an expert says.
In treating difficult pigmentary disorders such as melasma and postinflammatory hyperpigmentation (PIH), “The wave of the future will involve combination therapies. We have multiple agents that […]
Trial confirms superiority of combined calcipotriol-betamethasone formulation in patients with scalp psoriasis.
Monday, December 15th, 2008Trial confirms superiority of combined calcipotriol-betamethasone formulation in patients with scalp psoriasis.
MedWire (12/12, McDermid) reported that, according to a study published online Nov. 25 in the British Journal of Dermatology, “a randomized trial has confirmed the superiority of a combined calcipotriol and betamethasone dipropionate formulation over either of the individual drugs in patients with scalp […]
